摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3,5?二羟基胆甾-6-酮 | 13027-33-3

中文名称
3,5?二羟基胆甾-6-酮
中文别名
——
英文名称
3β,5-dihydroxy-5α-cholestan-6-one
英文别名
3β,5α-dihydroxycholestan-6-one;cholestan-3β,5α,6-one;cholesten-3β,5α-diol-6-one;cholestan-3β,5α-diol-6-one;5α-hydroxy-6-ketocholesterol;6-oxo-cholestane-3β,5α-diol;6-oxocholestane-5α,3β-diol;6-keto-5α-hydroxycholestanol;6-keto-5α-hydroxycholesterol;oncosterone;3β.5-Dihydroxy-5α-cholestanon-(6);3β,5-Dihydroxy-5α-cholestan-6-on;cholestane-3-β, 5-αdiol-6-one;3,5-dihydroxycholestan-6-one;Yakkasterone;(3S,5R,8S,9S,10R,13R,14S,17R)-3,5-dihydroxy-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-one
3,5?二羟基胆甾-6-酮化学式
CAS
13027-33-3
化学式
C27H46O3
mdl
——
分子量
418.66
InChiKey
SJZZRXMQSAXCFD-ZCBMJONGSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    234 °C
  • 沸点:
    528.9±45.0 °C(Predicted)
  • 密度:
    1.061±0.06 g/cm3(Predicted)
  • 溶解度:
    DMF:20mg/mL; DMSO:0.5mg/mL;乙醇:5mg/mL

计算性质

  • 辛醇/水分配系数(LogP):
    7
  • 重原子数:
    30
  • 可旋转键数:
    5
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.96
  • 拓扑面积:
    57.5
  • 氢给体数:
    2
  • 氢受体数:
    3

SDS

SDS:c63c2382f553d32d6577319414a6c75d
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • A mild oxidizing reagent for alcohols and 1,2-diols: o-iodoxybenzoic acid (IBX) in DMSO
    作者:Marco Frigerio、Marco Santagostino
    DOI:10.1016/0040-4039(94)80038-3
    日期:1994.10
    o-Iodoxybenzoic acid (IBX) smoothly oxidizes primary and secondary alcohols to aldehydes and ketones, respectively. 1,2-Diols are converted to α-ketols or α-diketones without any oxidative cleavage of the glycol CC bond. IBX oxidations are easily conducted in DMSO solution at room temperature, with yields ranging from good to quantitative.
    苯甲酸(IBX)分别将伯醇和仲醇平滑氧化为醛和酮。1,2-二醇可转化为α-酮醇或α-二酮,而乙二醇CC键没有任何氧化裂解。IBX氧化很容易在室温下的DMSO溶液中进行,收率范围从良好到定量。
  • Brominating and oxidizing agent and method of using same
    申请人:Interx Research Corporation
    公开号:US04009178A1
    公开(公告)日:1977-02-22
    There is provided a brominating and oxidizing agent of the formula: ##STR1## wherein R.sub.1, R.sub.2, R.sub.3 and R.sub.4 which may be the same or different, represents a member selected from the group consisting of a hydrogen atom, a C.sub.1 -C.sub.22 straight or branched alkyl group, a phenyl group, and a substituted phenyl group whose substituents are selected from the group consisting of a methoxy group, a nitro group, a cyano group, a halogen atom (Br, Cl, I), a C.sub.1 -C.sub.2 dialkylamino group, a C.sub.1 -C.sub.2 dialkylaminomethyl group, a C.sub.1 -C.sub.2 dialkylaminoethyl group, a C.sub.1 -C.sub.2 dialkylammoniummethyl group, a C.sub.1 -C.sub.2 dialkylammoniumethyl group, a C.sub.1 -C.sub.2 trialkylammoniummethyl group, a C.sub.1 -C.sub.2 trialkylammoniumethyl group, a COOR.sub.5 group, and a CON(R.sub.5).sub.2 group, wherein R.sub.5 represents a C.sub.1 -C.sub.8 straight or branched alkyl group. The compounds falling within formula (I) find wide application as brominating and oxidizing agents in a number of organic reactions in which the prior art compound, N-bromosuccinimide has been employed to date. In comparison to N-bromosuccinimide, the compounds of the instant invention are characterized as being extremely stable to degradation and less polar with respect to their N-Br bond than N-bromosuccinimide such that promotion of "radical" bromine release is achieved with minimal positive bromine release.
    提供一种化和氧化剂,其化学式为:##STR1## 其中R.sub.1、R.sub.2、R.sub.3和R.sub.4可以相同也可以不同,代表所选自群组的成员,包括氢原子、C.sub.1-C.sub.22直链或支链烷基、苯基和取代苯基,其取代基选自群组,包括甲氧基、硝基、基、卤原子()、C.sub.1-C.sub.2二烷基基、C.sub.1-C.sub.2二烷基甲基、C.sub.1-C.sub.2二烷基乙基、C.sub.1-C.sub.2二烷基甲基、C.sub.1-C.sub.2二烷基乙基、C.sub.1-C.sub.2三烷基甲基、C.sub.1-C.sub.2三烷基乙基、COOR.sub.5基团和CON(R.sub.5).sub.2基团,其中R.sub.5代表C.sub.1-C.sub.8直链或支链烷基。符合式(I)的化合物在许多有机反应中作为化和氧化剂广泛应用,其中迄今为止已经使用的先前技术化合物N-代琥珀酰亚胺。与N-代琥珀酰亚胺相比,本发明的化合物具有极高的稳定性和较低的极性,其N-Br键相对于N-代琥珀酰亚胺来说,促进“自由基”释放的效果更好,释放量极小。
  • Methods for Determining the Oncogenic Condition of Cell, Uses Thereof, and Methods for Treating Cancer
    申请人:INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE)
    公开号:US20170176446A1
    公开(公告)日:2017-06-22
    The invention relates to methods for detecting the oncogenic condition of cells, including step where the amount of the OCDO compound in said cells is measured, and to the uses thereof. The invention further relates to OCDO inhibitors for use in methods for treating cancer.
    这项发明涉及检测细胞的致癌状态的方法,包括测量所述细胞中OCDO化合物的数量的步骤,以及其用途。该发明还涉及用于治疗癌症方法中使用的OCDO抑制剂
  • NANOMATERIALS
    申请人:Guide Therapeutics, Inc.
    公开号:US20210169804A1
    公开(公告)日:2021-06-10
    Lipid nanoparticle compositions for delivery of nucleic acids are described. The lipid nanoparticle may contain a conformationally constrained ionizable lipid as part of the composition. These compositions may allow for delivery of cargo without the need for a targeting ligand.
    描述了用于传递核酸的脂质纳米粒子组合物。脂质纳米粒子可能包含作为组合物的一部分的构象受限的可离子化脂质。这些组合物可能允许传递货物而无需靶向配体
  • Tin(<scp>II</scp>) chloride dihydrate–a mild reagent for the transformation of 6-nitro-Δ<sup>5</sup>-steroids to 5α-hydroxy-6-ketosteroids
    作者:Gireesh M. Singhal、Nalin B. Das、Ram P. Sharma
    DOI:10.1039/c39900000498
    日期:——
    Reaction of excess hydrated tin(II) chloride with 6-nitro-Δ5-steroids (1a–g) and (5) in tetrahydrofuran furnishes 5α-hydroxy-6-ketosteroids (2a–g) and (6) respectively, in good yields.
    过量氯化亚锡与6-硝基-Δ5-甾体(1a-g)及(5)在四氢呋喃中的反应,分别以良好产率得到5α-羟基-6-酮甾体(2a-g)及(6)。
查看更多

同类化合物

(5β)-17,20:20,21-双[亚甲基双(氧基)]孕烷-3-酮 (5α)-2′H-雄甾-2-烯并[3,2-c]吡唑-17-酮 (3β,20S)-4,4,20-三甲基-21-[[[三(异丙基)甲硅烷基]氧基]-孕烷-5-烯-3-醇-d6 (25S)-δ7-大发酸 (20R)-孕烯-4-烯-3,17,20-三醇 (11β,17β)-11-[4-({5-[(4,4,5,5,5-五氟戊基)磺酰基]戊基}氧基)苯基]雌二醇-1,3,5(10)-三烯-3,17-二醇 齐墩果酸衍生物1 黄麻属甙 黄芪皂苷III 黄芪皂苷 II 黄芪甲苷 IV 黄芪甲苷 黄肉楠碱 黄果茄甾醇 黄杨醇碱E 黄姜A 黄夹苷B 黄夹苷 黄夹次甙乙 黄夹次甙乙 黄夹次甙丙 黄体酮环20-(乙烯缩醛) 黄体酮杂质EPL 黄体酮杂质1 黄体酮杂质 黄体酮杂质 黄体酮EP杂质M 黄体酮EP杂质G(RRT≈2.53) 黄体酮EP杂质F 黄体酮6-半琥珀酸酯 黄体酮 17alpha-氢过氧化物 黄体酮 11-半琥珀酸酯 黄体酮 麦角甾醇葡萄糖苷 麦角甾醇氢琥珀酸盐 麦角甾烷-6-酮,2,3-环氧-22,23-二羟基-,(2b,3b,5a,22R,23R,24S)-(9CI) 麦角甾烷-3,6,8,15,16-五唑,28-[[2-O-(2,4-二-O-甲基-b-D-吡喃木糖基)-a-L-呋喃阿拉伯糖基]氧代]-,(3b,5a,6a,15b,16b,24x)-(9CI) 麦角甾烷-26-酸,5,6:24,25-二环氧-14,17,22-三羟基-1-羰基-,d-内酯,(5b,6b,14b,17a,22R,24S,25S)-(9CI) 麦角甾-8-烯-3-醇 麦角甾-8,24(28)-二烯-26-酸,7-羟基-4-甲基-3,11-二羰基-,(4a,5a,7b,25S)- 麦角甾-7,22-二烯-3-酮 麦角甾-7,22-二烯-17-醇-3-酮 麦角甾-5,24-二烯-26-酸,3-(b-D-吡喃葡萄糖氧基)-1,22,27-三羟基-,d-内酯,(1a,3b,22R)- 麦角甾-5,22,25-三烯-3-醇 麦角甾-4,6,8(14),22-四烯-3-酮 麦角甾-1,4-二烯-3-酮,7,24-二(乙酰氧基)-17,22-环氧-16,25-二羟基-,(7a,16b,22R)-(9CI) 麦角固醇 麦冬皂苷D 麦冬皂苷D 麦冬皂苷 B